clinical diagnostics

2 articles
BenzingaBenzinga··Prnewswire

Roche Expands Mass Spectrometry Diagnostics with FDA's 'Moderate Complexity' Approval

Roche's Ionify® steroid assays receive FDA's moderate complexity designation, expanding access to mass spectrometry-based hormone testing across routine clinical laboratories.
RHHBYFDA approvalmass spectrometry
GlobeNewswire Inc.GlobeNewswire Inc.··Custom Market Insights

Microplate Systems Market to Double to $2.88B by 2035 on Biotech Boom

Global microplate systems market projected to grow from $1.42B (2025) to $2.88B (2035) at 10.7% CAGR, driven by pharma R&D spending and automation demand.
TMODHRGLWABIO+2automationmarket growth